4//SEC Filing
Geller Matthew 4
Accession 0001062993-11-002527
CIK 0000875622other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 6:09 AM ET
Size
6.6 KB
Accession
0001062993-11-002527
Insider Transaction Report
Form 4
Geller Matthew
Director
Transactions
- Sale
Common Stock, $0.001 par value
2011-06-06$24.23/sh−5,000$121,135→ 5,000 total - Sale
Common Stock, $0.001 par value
2011-06-07$24.57/sh−5,000$122,871→ 0 total
Footnotes (2)
- [F1]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.10 to $24.38. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $24.52 to $24.69. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001446201
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 6:09 AM ET
- Size
- 6.6 KB